59.50EUR+0.68%Mkt Cap: 3.57B $P/E: —Today
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medica…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap3.57B $
Enterprise Value198.99M $
Revenue (TTM)1.15B $
Gross Profit1.15B $
Net Income (TTM)628.41M $
Revenue/Share20.91 USD
Last Price59.50 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees10
CountryDE
SectorHealthcare
IndustryBiotechnology
ISINCH0038389992
Valuation
P/E (Trailing)—
P/E (Forward)26.89
PEG—
EV/EBITDA—
EV/Revenue0.17
P/S3.04
P/B0.98
EPS (TTM)-8.60
EPS (Forward)2.17
52W Range
34.0099% of range59.70
52W High59.70 EUR
52W Low34.00 EUR
Profitability
Gross Margin100.00%
Oper. Margin97.74%
EBITDA Margin0.00%
Profit Margin98.49%
ROE20.81%
ROA20.75%
Growth
Revenue Growth116257.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF329.11M $
CapEx (TTM)—
FCF Margin233.15%
FCF Yield75.29%
Net Debt-3.34B $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio583.97
Quick Ratio583.91
Book Value/Sh59.56 EUR
Cash/Share55.78 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate2.250 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio87.34%
Ex-Div DateMar 23, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)62.00 EUR
Upside (mean)+4.2%
Target Range62.00 EUR – 62.00 EUR
# Analysts1
Ownership
Shares Out.55.15M
Float—
Insiders0.08%
Institutions19.25%
Technical
SMA 5033.40 (+78.1%)
SMA 20033.40 (+78.1%)
Beta0.66
S&P 52W Chg18.16%
Avg Vol (30d)8.16K
Avg Vol (10d)0
Technical Indicators
RSI (14)71.8
MACD1.3749
MACD Signal1.1299
MACD Hist.+0.2450
BB Upper59.08 EUR
BB Middle56.02 EUR
BB Lower52.95 EUR
BB Width10.95%
ATR (14)1.202 EUR
Vol Ratio (20d)0.93x